These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8179457)

  • 21. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
    Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Audit of anticoagulant therapy of pulmonary embolus, deep vein thrombosis and thrombophlebitis.
    Meinhold JM; Reale EO; Miller WA
    Am J Hosp Pharm; 1979 Feb; 36(2):214-8. PubMed ID: 420210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
    Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S
    Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of weight, sex, age, clinical diagnosis, and thromboplastin reagent on steady-state intravenous heparin requirements.
    White RH; Zhou H; Woo L; Mungall D
    Arch Intern Med; 1997 Nov; 157(21):2468-72. PubMed ID: 9385298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.
    Hull RD; Raskob GE; Hirsh J; Jay RM; Leclerc JR; Geerts WH; Rosenbloom D; Sackett DL; Anderson C; Harrison L
    N Engl J Med; 1986 Oct; 315(18):1109-14. PubMed ID: 3531862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin therapy in pediatric patients: a prospective cohort study.
    Andrew M; Marzinotto V; Massicotte P; Blanchette V; Ginsberg J; Brill-Edwards P; Burrows P; Benson L; Williams W; David M
    Pediatr Res; 1994 Jan; 35(1):78-83. PubMed ID: 8134203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of APTT monitoring of low-dose heparin dosage in hip surgery.
    Poller L; Taberner DA; Sandilands DG; Galasko CS
    Thromb Haemost; 1982 Feb; 47(1):50-3. PubMed ID: 7071805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis.
    Brandjes DP; Heijboer H; Büller HR; de Rijk M; Jagt H; ten Cate JW
    N Engl J Med; 1992 Nov; 327(21):1485-9. PubMed ID: 1406880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative trial of anti-factor Xa levels versus the activated partial thromboplastin time for heparin monitoring.
    Vandiver JW; Vondracek TG
    Hosp Pract (1995); 2013 Apr; 41(2):16-24. PubMed ID: 23545756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization and effectiveness of a weight-based heparin nomogram at a large academic medical center.
    Balcezak TJ; Krumholz HM; Getnick GS; Vaccarino V; Lin ZQ; Cadman EC
    Am J Manag Care; 2000 Mar; 6(3):329-38. PubMed ID: 10977433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.
    Levine MN; Hirsh J; Gent M; Turpie AG; Weitz J; Ginsberg J; Geerts W; LeClerc J; Neemeh J; Powers P
    Thromb Haemost; 1995 Aug; 74(2):606-11. PubMed ID: 8584992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aging and heparin-related bleeding.
    Campbell NR; Hull RD; Brant R; Hogan DB; Pineo GF; Raskob GE
    Arch Intern Med; 1996 Apr; 156(8):857-60. PubMed ID: 8774204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature.
    Myzienski AE; Lutz MF; Smythe MA
    Pharmacotherapy; 2010 Mar; 30(3):324. PubMed ID: 20180615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of a heparin nomogram for treatment of patients with venous thromboembolism in a community hospital.
    de Groot MR; Büller HR; ten Cate JW; van Marwijk Kooy M
    Thromb Haemost; 1998 Jul; 80(1):70-3. PubMed ID: 9684788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosis.
    Stricker H; Marchetti O; Haeberli A; Mombelli G
    Thromb Haemost; 1999 Oct; 82(4):1227-31. PubMed ID: 10544903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inability of the activated partial thromboplastin time to predict heparin levels. Time to reassess guidelines for heparin assays.
    Baker BA; Adelman MD; Smith PA; Osborn JC
    Arch Intern Med; 1997 Nov; 157(21):2475-9. PubMed ID: 9385299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy of deep vein thrombosis.
    Turpie AG
    Herz; 1989 Dec; 14(6):341-7. PubMed ID: 2695442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis--a randomized clinical trial.
    Pini M; Pattachini C; Quintavalla R; Poli T; Megha A; Tagliaferri A; Manotti C; Dettori AG
    Thromb Haemost; 1990 Oct; 64(2):222-6. PubMed ID: 2270531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.
    Hull R; Hirsh J; Jay R; Carter C; England C; Gent M; Turpie AG; McLoughlin D; Dodd P; Thomas M; Raskob G; Ockelford P
    N Engl J Med; 1982 Dec; 307(27):1676-81. PubMed ID: 6755255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.